- Home
- SSSS vs SRZN Comparison
SSSS vs SRZN Comparison
Compare SSSS & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$24.54
Company Overview
Basic Information| Metric | SSSS | SRZN |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.4M | 213.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SSSS | SRZN |
|---|---|---|
| Price | $9.53 | $24.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $10.13 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 205.0K | 155.5K |
| Earning Date | 03-10-2026 | 03-30-2026 |
| Dividend Yield | ★ 10.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.61 | N/A |
| Revenue | $2,354,933.00 | ★ $3,604,000.00 |
| Revenue This Year | $4,765.38 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.64 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.21 | $5.90 |
| 52 Week High | $10.34 | $25.85 |
Technical Indicators
Market Signals| Indicator | SSSS | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 63.73 |
| Support Level | $8.70 | $21.07 |
| Resistance Level | $9.87 | $25.85 |
| Average True Range (ATR) | 0.37 | 2.29 |
| MACD | 0.02 | 0.32 |
| Stochastic Oscillator | 62.90 | 92.42 |
Price Performance
Historical Comparison SSSS
SRZN
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).